Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Infect Control ; 44(6): e91-4, 2016 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-26897700

RESUMO

There were 256 health care workers in 39 facilities who were interviewed about their perceptions of the quality of care of patients with and without multidrug-resistant organisms based on a standardized questionnaire. There are remarkable differences in the responses between facility types (acute care hospitals, long-term care hospitals, rehabilitation hospitals, and home care services). Hygiene management must be specifically tailored to the requirements of each facility.


Assuntos
Atitude do Pessoal de Saúde , Farmacorresistência Bacteriana Múltipla , Conhecimentos, Atitudes e Prática em Saúde , Pessoal de Saúde , Adolescente , Adulto , Idoso , Uso de Medicamentos/normas , Feminino , Alemanha , Humanos , Controle de Infecções/métodos , Masculino , Pessoa de Meia-Idade , Inquéritos e Questionários , Adulto Jovem
2.
Eur J Clin Microbiol Infect Dis ; 33(10): 1817-22, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24838677

RESUMO

Infections with methicillin-resistant Staphylococcus aureus (MRSA) are assumed to have a high economic impact due to increased hygienic measures and prolonged hospital length of stay. However, surveys on the real expenditure for the prevention and treatment of MRSA are scarce, in particular with regard to the German Diagnosis-Related Groups (G-DRG) payment system. The aim of our study is to empirically assess the additional cost for MRSA management measures and to identify the main cost drivers in the whole process from the hospital's point of view. We conducted a one-year retrospective analysis of MRSA-positive cases in a German university hospital and determined the cost of hygienic measures, laboratory costs, and opportunity costs due to isolation time and extended lengths of stay. A total of 182 cases were included in the analysis. The mean length of hospital stay was 22.75 days and the mean time in isolation was 17.08 days, respectively. Overall, the calculated MRSA-attributable costs were 8,673.04 per case, with opportunity costs making up, by far, the largest share (77.45 %). Our study provides a detailed up-to-date analysis of MRSA-attributed costs in a hospital. It allows a current comparison to previous studies worldwide. Moreover, it offers the prerequisites to investigate the adequate reimbursement of MRSA burden in the DRG payment system and to assess the efficiency of targeted hygienic measures in the prevention of MRSA.


Assuntos
Administração de Caso/economia , Hospitalização/economia , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Infecções Estafilocócicas/economia , Infecções Estafilocócicas/microbiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Feminino , Alemanha , Hospitais Universitários , Humanos , Lactente , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Isolamento de Pacientes/economia , Estudos Retrospectivos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...